Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Stephanie Gardner

Concepts (212)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Education, Pharmacy
3
2012
143
0.880
Why?
Rural Health Services
2
2024
166
0.840
Why?
Curriculum
5
2012
402
0.760
Why?
Students, Pharmacy
4
2010
121
0.660
Why?
Schools, Pharmacy
2
2010
54
0.660
Why?
Blood Pressure
8
2008
512
0.610
Why?
Telemedicine
1
2024
448
0.600
Why?
Dental Caries
1
2016
8
0.540
Why?
Schools, Dental
1
2016
7
0.530
Why?
Tetrazoles
2
2008
41
0.530
Why?
Hypertension
5
2008
533
0.460
Why?
Dietary Supplements
7
2005
443
0.410
Why?
Faculty
2
2010
72
0.400
Why?
Plant Preparations
5
2005
38
0.380
Why?
Career Choice
1
2012
111
0.380
Why?
Pharmacy
1
2012
58
0.380
Why?
Patient Care Team
2
2003
254
0.380
Why?
Antihypertensive Agents
3
2003
117
0.360
Why?
Biphenyl Compounds
1
2008
31
0.320
Why?
Angiotensin II Type 1 Receptor Blockers
1
2008
43
0.310
Why?
School Admission Criteria
1
2008
37
0.310
Why?
Benzimidazoles
1
2008
48
0.310
Why?
Blood Pressure Monitoring, Ambulatory
6
2008
35
0.310
Why?
Diabetes Mellitus, Type 1
2
2003
198
0.310
Why?
Ephedrine
5
2003
21
0.310
Why?
Clinical Competence
2
2010
393
0.310
Why?
Arkansas
4
2024
1978
0.300
Why?
Delivery of Health Care
2
2024
309
0.300
Why?
Niacin
2
1997
5
0.290
Why?
Diabetes Mellitus, Type 2
3
2004
476
0.280
Why?
Intergenerational Relations
1
2006
4
0.280
Why?
Angiotensin Receptor Antagonists
2
2004
19
0.280
Why?
Humans
36
2024
49978
0.270
Why?
Probucol
1
2005
3
0.270
Why?
Coronary Restenosis
1
2005
31
0.260
Why?
Interprofessional Relations
1
2006
85
0.260
Why?
Angiotensin II
2
2004
157
0.250
Why?
Alkaloids
3
2000
32
0.240
Why?
Hospitals, Rural
1
2024
15
0.230
Why?
Phytotherapy
2
2003
44
0.230
Why?
Ephedra
1
2003
8
0.230
Why?
Electrocardiography, Ambulatory
1
2003
23
0.220
Why?
Rural Health
1
2024
87
0.220
Why?
Hemostasis
1
2003
55
0.220
Why?
Self Care
1
2003
136
0.210
Why?
Community Pharmacy Services
1
2003
68
0.210
Why?
Administrative Personnel
1
2002
13
0.200
Why?
Ephedra sinica
2
1998
2
0.200
Why?
Imidazoles
1
2003
119
0.200
Why?
Academic Medical Centers
1
2002
144
0.190
Why?
Education, Medical, Undergraduate
1
2002
82
0.190
Why?
Patient Education as Topic
1
2003
302
0.180
Why?
Male
20
2012
25243
0.170
Why?
Rural Population
1
2024
540
0.170
Why?
Cytochrome P-450 Enzyme System
3
2005
195
0.160
Why?
Hypercholesterolemia
2
1997
36
0.160
Why?
Chromatography, High Pressure Liquid
2
2004
349
0.160
Why?
Attitude of Health Personnel
1
2002
347
0.160
Why?
Erectile Dysfunction
1
1999
85
0.150
Why?
Pravastatin
1
1997
18
0.150
Why?
Primary Health Care
1
2001
358
0.150
Why?
Anticholesteremic Agents
1
1997
28
0.150
Why?
Female
19
2012
26474
0.150
Why?
Heart Rate
5
2003
293
0.140
Why?
Lovastatin
1
1996
9
0.140
Why?
Sodium
2
1996
92
0.140
Why?
Hypolipidemic Agents
1
1996
27
0.140
Why?
Erythromycin
1
1996
10
0.130
Why?
Hyperlipidemias
1
1996
49
0.130
Why?
Torsades de Pointes
1
1996
15
0.130
Why?
Adult
13
2022
13236
0.130
Why?
Polyethylene Glycols
1
1995
93
0.130
Why?
Enzyme Inhibitors
1
1997
391
0.120
Why?
Pharmacies
1
1995
61
0.120
Why?
Pilot Projects
2
2008
699
0.110
Why?
Aged
10
2008
9310
0.110
Why?
Dose-Response Relationship, Drug
3
2008
1376
0.110
Why?
Clinical Trials as Topic
3
2005
461
0.110
Why?
Middle Aged
10
2008
12069
0.110
Why?
Tomography, Emission-Computed
1
1992
53
0.100
Why?
Education, Pharmacy, Continuing
1
1991
4
0.100
Why?
Accreditation
1
1991
60
0.100
Why?
Education, Medical, Continuing
1
1991
68
0.100
Why?
Organizational Policy
1
2010
40
0.090
Why?
Heart Failure
1
1995
458
0.090
Why?
Pharmacists
1
1991
144
0.090
Why?
Social Environment
1
2010
80
0.090
Why?
Anti-Bacterial Agents
1
1996
744
0.090
Why?
Students
1
2012
210
0.090
Why?
Drug Interactions
4
2004
206
0.090
Why?
Phenotype
4
2005
729
0.090
Why?
Plant Extracts
2
2004
190
0.090
Why?
Misoprostol
1
2008
5
0.080
Why?
Diclofenac
1
2008
9
0.080
Why?
Drug Therapy, Combination
3
2004
377
0.080
Why?
Sodium Chloride
1
2008
57
0.080
Why?
Blood Glucose
2
2003
438
0.080
Why?
Guidelines as Topic
1
2008
111
0.080
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2008
121
0.070
Why?
Guideline Adherence
1
2008
133
0.070
Why?
Drugs, Investigational
1
2005
14
0.070
Why?
Valerian
1
2005
2
0.060
Why?
Cimicifuga
1
2005
8
0.060
Why?
Kava
1
2005
11
0.060
Why?
Hydrastis
1
2005
10
0.060
Why?
Educational Measurement
1
2007
208
0.060
Why?
Citrus
1
2004
6
0.060
Why?
Echinacea
1
2004
5
0.060
Why?
Aryl Hydrocarbon Hydroxylases
1
2005
74
0.060
Why?
Molecular Structure
1
2005
297
0.060
Why?
Cognition
1
2007
338
0.060
Why?
Prospective Studies
3
2008
2364
0.060
Why?
Kidney
1
2008
665
0.060
Why?
Antioxidants
1
2005
249
0.060
Why?
Cost Savings
1
2003
58
0.060
Why?
Central Nervous System Stimulants
2
2004
213
0.060
Why?
Diastole
1
2003
69
0.060
Why?
Bradycardia
1
2003
36
0.060
Why?
Systole
1
2003
68
0.060
Why?
Receptors, Angiotensin
1
2003
13
0.050
Why?
Prescription Fees
1
2003
14
0.050
Why?
Tachycardia, Ventricular
1
2003
44
0.050
Why?
Plants, Medicinal
2
2000
35
0.050
Why?
Health Services Research
1
2003
151
0.050
Why?
Reference Values
1
2003
310
0.050
Why?
Mixed Function Oxygenases
1
2002
25
0.050
Why?
Amphetamines
1
2002
29
0.050
Why?
Seroepidemiologic Studies
1
2022
43
0.050
Why?
Kidney Diseases
1
2004
214
0.050
Why?
Adolescent
2
2008
6357
0.050
Why?
Time Factors
3
2005
2903
0.050
Why?
Cytochrome P-450 CYP2E1
1
2002
113
0.050
Why?
Program Evaluation
1
2003
354
0.050
Why?
Models, Educational
1
2002
30
0.050
Why?
Patient Compliance
1
2003
230
0.050
Why?
Sympathomimetics
2
1998
21
0.050
Why?
Methylphenidate
1
2002
75
0.050
Why?
Body Weight
1
2003
513
0.050
Why?
Midazolam
3
2005
38
0.050
Why?
Attention Deficit Disorder with Hyperactivity
1
2002
173
0.050
Why?
Caffeine
3
2005
67
0.040
Why?
Herb-Drug Interactions
3
2005
31
0.040
Why?
Body Mass Index
1
2003
652
0.040
Why?
Plants, Toxic
1
1999
10
0.040
Why?
Feasibility Studies
1
2001
375
0.040
Why?
Evaluation Studies as Topic
1
1998
107
0.040
Why?
Child
2
2008
6849
0.040
Why?
Fructosamine
1
1997
1
0.040
Why?
Lipoprotein(a)
1
1997
3
0.040
Why?
Cross-Over Studies
3
2008
224
0.040
Why?
Cholesterol, LDL
1
1997
34
0.040
Why?
Drugs, Chinese Herbal
1
1997
5
0.040
Why?
Comorbidity
1
1999
615
0.040
Why?
Cross-Sectional Studies
1
2022
1557
0.040
Why?
United States
2
2002
4863
0.040
Why?
Nifedipine
1
1996
25
0.040
Why?
Pancreas Transplantation
1
1996
21
0.030
Why?
Ethanol
1
1999
340
0.030
Why?
Circadian Rhythm
1
1996
87
0.030
Why?
Calcium Channel Blockers
1
1996
62
0.030
Why?
Pharmaceutical Vehicles
1
1995
3
0.030
Why?
Electrolytes
1
1995
26
0.030
Why?
Models, Biological
1
1999
727
0.030
Why?
Reproducibility of Results
1
1998
1193
0.030
Why?
Kidney Transplantation
1
1996
175
0.030
Why?
Isoenzymes
2
2005
168
0.030
Why?
Drug Administration Schedule
2
2005
376
0.030
Why?
Ginkgo biloba
2
2005
8
0.030
Why?
Panax
2
2005
6
0.030
Why?
Allyl Compounds
2
2005
10
0.030
Why?
Hypericum
2
2005
13
0.030
Why?
Sulfides
2
2005
28
0.030
Why?
Electrocardiography
1
1996
257
0.030
Why?
Critical Care
1
1996
213
0.030
Why?
Treatment Outcome
1
2003
5141
0.030
Why?
Databases, Factual
1
1995
658
0.030
Why?
Specialty Boards
1
1991
24
0.030
Why?
Capsules
2
2005
30
0.030
Why?
Mass Screening
1
1995
353
0.030
Why?
Public Policy
1
1991
38
0.020
Why?
Retrospective Studies
1
2003
6110
0.020
Why?
Data Collection
1
1991
279
0.020
Why?
Animals
1
2005
13187
0.020
Why?
Aged, 80 and over
1
1996
3129
0.020
Why?
Sex Factors
2
2002
691
0.020
Why?
Risk Factors
1
1995
3613
0.020
Why?
Double-Blind Method
1
2008
681
0.020
Why?
Chlorzoxazone
1
2005
5
0.020
Why?
Debrisoquin
1
2004
1
0.020
Why?
Serenoa
1
2004
7
0.020
Why?
GABA Modulators
1
2004
9
0.020
Why?
Adrenergic Agents
1
2004
15
0.020
Why?
Solubility
1
2004
69
0.020
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2004
65
0.010
Why?
Administration, Oral
1
2005
426
0.010
Why?
Patient Selection
1
2005
253
0.010
Why?
Kinetics
1
2004
623
0.010
Why?
Cytochrome P-450 CYP3A
1
2002
78
0.010
Why?
Analysis of Variance
1
2002
562
0.010
Why?
Sleep
1
2002
183
0.010
Why?
Drug Labeling
1
2000
11
0.010
Why?
Drug and Narcotic Control
1
2000
10
0.010
Why?
Predictive Value of Tests
1
2002
903
0.010
Why?
Metabolic Clearance Rate
1
1997
68
0.010
Why?
Half-Life
1
1997
84
0.010
Why?
Compartment Syndromes
1
1996
16
0.010
Why?
Area Under Curve
1
1997
182
0.010
Why?
Delayed-Action Preparations
1
1996
47
0.010
Why?
Pharmaceutical Preparations
1
1996
77
0.010
Why?
Dopamine
1
1996
171
0.010
Why?
Regression Analysis
1
1996
395
0.010
Why?
Immunosuppressive Agents
1
1996
221
0.010
Why?
Gardner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description